Evidence map›Paper›PMID 42434980›Full record

ArticleJournal of proteome research2026

Protein Enrichment from Ascites Fluid Using Nanotrap Hydrogel Particle Technology.

Carly A I Twigg, Kathleen M Madden, Kristin L M Boylan, Amy P N Skubitz, Stefani N Thomas

Abstract read
In one paragraph

Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carly A I TwiggUniversity of Minnesota , Department of Laboratory Medicine and Pathology, Minneapolis, Minnesota55455, United States.
Kathleen M MaddenUniversity of Minnesota , Department of Laboratory Medicine and Pathology, Minneapolis, Minnesota55455, United States.
Kristin L M BoylanUniversity of Minnesota , Department of Laboratory Medicine and Pathology, Minneapolis, Minnesota55455, United States.
Amy P N SkubitzUniversity of Minnesota , Department of Laboratory Medicine and Pathology, Minneapolis, Minnesota55455, United States.
Stefani N ThomasUniversity of Minnesota , Department of Laboratory Medicine and Pathology, Minneapolis, Minnesota55455, United States.ORCID 0000-0003-1679-5453

Funding

A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detectionR01CA262153 · NCI · UNIVERSITY OF MINNESOTA · PI SKUBITZ, AMY PATRICE · 2021 to 2025
$2.5M
Preclinical development and validation of targeted mass spectrometry assays for serous ovarian cancer diagnosisR21CA288922 · NCI · UNIVERSITY OF MINNESOTA · PI THOMAS, STEFANI · 2025 to 2025
$387k
NCI NIH HHS R01 CA262153NCI NIH HHS R01CA262153NCI NIH HHS R21 CA288922NCI NIH HHS R21CA288922
6 · The paper itself

Abstract

Ascites fluid is a clinically relevant biological matrix commonly present in patients with high-grade serous ovarian carcinoma (HGSOC). Enrichment or depletion methods are required to compress the dynamic range of the ascites fluid proteome prior to mass spectrometry (MS)-based proteomic analysis. In this study, we evaluated the ability of Nanotrap Protein Enrichment Affinity Kits (PEAK) to enable the MS detection of lower-abundance proteins in ascites fluid in a biomarker discovery workflow. Nanotrap PEAK contains magnetic hydrogel nanoparticles (A, B, and C), whose complementary chemistries selectively isolate low-abundance proteins while excluding high-abundance proteins to enhance the depth of proteome coverage. The Nanotrap particles have previously been evaluated for plasma, serum, CSF, and urine protein enrichment but not ascites fluid. The use of the Nanotrap particles resulted in >2-3× more identified proteins than the Neat ascites. An average of 61% of the proteins were enriched by the Nanotrap particles, whereas 39% were depleted. The maximum number of proteins identified among 10 HGSOC-derived ascites samples processed using the Nanotrap particles was 3480-4000 vs 1505 in the Neat samples. The use of Nanotrap particles is a cost-efficient and readily scalable approach for MS-based proteomic biomarker discovery studies in ascites fluid.

Indexed as

Ascitic FluidNanoparticlesOvarian NeoplasmsProteomeProteomicsAscitesBiomarkers, TumorFemaleHumansHydrogelsBiomarkers, TumorHydrogelsProteomeascitesbiomarkerenrichmentmass spectrometrynanoparticleovarian cancerproteomics

Identifiers

PMID42434980
PMCPMC13459538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.